Abstract
Objective
To investigate the association between disease activity and cognitive impairment in patients with rheumatoid arthritis (RA).
Methods
A total of 464 patients from the rheumatoid arthritis registry of two academic centers, Siriraj and Phramongkutklao hospitals, were included. Demographic, clinical, and laboratory data related to disease activity and functional status were collected. Cognitive function was assessed using the Thai version of the Montreal Cognitive Assessment (MoCA-T). Subjects were classified as cognitively impaired if they scored less than 25.
Results
Most subjects (85%) were female with a mean age ± SD of 59.2 ± 11.4 years old and a median (range) educational level of 9 (4–14) years. They were long-standing RA patients (median disease duration (range) of 9.9 (5.1–16.6) years) and had moderate cumulative disease activity (mean DAS28 ± SD of 3.5 ± 0.81) and mild functional impairment (median HAQ (range) 0.5 (0.13–1.10)). Seventy percent of the patients were classified as having cognitive impairment. The patients with cognitive impairment significantly impaired in all domains, especially in visuospatial/executive, language, and abstraction. In multiple logistic regression analyses, old age (RR 3.45, 95% CI 2–6, p < 0.001), low education (RR 10.8, 95% CI 5.3–22.1, p < 0.001), and high cumulative disease activity (RR 2.2, 95% CI 1.07–4.7, p = 0.033) were independently associated with cognitive impairment.
Conclusion
High cumulative RA disease activity is associated with cognitive impairment. Therefore, treat-to-target aimed at low disease activity or remission may be beneficial for preventing cognitive decline in RA patients.
Similar content being viewed by others
References
Engel A, Roberts J, Burch TA (1966) Rheumatoid arthritis in adults. Vital Health Stat 11(17):1–43
Wolfe A (1968) The epidemiology of rheumatoid arthritis: a review. I. Surveys. Bull Rheum Dis 19(2):518–523
Mikkelsen WM, Dodge HJ, Duff IF, Kato H (1967) Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959–60. J Chronic Dis 20(6):351–369
Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P (1998) Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community oriented programme for the control of rheumatic disease. J Rheumatol 25(7):1382–1387
Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A (2013) A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology 52(1):99–110. https://doi.org/10.1093/rheumatology/kes262
Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G, Provinciali L, Danieli G (2002) Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 20(4):491–497
Katchamart W, Koolvisoot A, Chiowchanwisawakit P, Aromdee E, Nilkanuwong S, Prarewesithi L (2004) Cognitive dysfunction in systemic lupus erythematosus patients at Siriraj Hospital. Siriraj Med J 56:485–492
Kurne A, Karabudak R, Karadag Ö, Yalcin-Cakmakli G, Karli-Oguz K, Yavuz K, Calgüneri M, Topcuoglu MA (2009) An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis. Rheumatol Int 29(11):1349–1353. https://doi.org/10.1007/s00296-008-0810-6
Coluccia D, Wolf OT, Kollias S, Roozendaal B, Forster A, de Quervain DJ (2008) Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci 28(13):3474–3478. https://doi.org/10.1523/jneurosci.4893-07.2008
Pamuk ON, Kisacik B, Pamuk GE, Onat AM, Sayarlioglu M, Donmez S, Pehlivan Y, Keystone EC (2013) Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study. Rheumatol Int 33(10):2631–2635. https://doi.org/10.1007/s00296-013-2792-2
Gkaliagkousi E, Gavriilaki E, Doumas M, Petidis K, Aslanidis S, Stella D (2012) Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 18(8):422–430. https://doi.org/10.1097/RHU.0b013e31827846b1
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732. https://doi.org/10.1002/art.20878
Appenzeller S, Bertolo MB, Costallat LT (2004) Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 26(5):339–343
Shin SY, Katz P, Wallhagen M, Julian L (2012) Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res 64(8):1144–1150. https://doi.org/10.1002/acr.21683
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Smith T, Gildeh N, Holmes C (2007) The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatr 52(5):329–332. https://doi.org/10.1177/070674370705200508
Tangwongchai S, Phanasathit M, Charernboon T, Akkayagorn L, Hemrungrojn S, Phanthumchinda K, ZA N (2009) The validity of Thai version of the Montreal Cognitive Assessment (MoCA-T). Dement Neuropsychol 3(2):172
Julayanont P, Phillips N, Chertkow H, Nasreddine ZS (2013) Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner AJ (ed) Cognitive screening instruments: a practical approach. Springer London, London, pp 111–151. doi:https://doi.org/10.1007/978-1-4471-2452-8_6
Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheum Intern 35(10):1693–1699. https://doi.org/10.1007/s00296-015-3271-8
Darawankul B, Chaiamnuay S, Pakchotanon R, Asavatanabodee P, Narongroeknawin P (2015) The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort. Clin Rheumatol 34(1):43–49. https://doi.org/10.1007/s10067-014-2749-1
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588. https://doi.org/10.1136/ard.2010.138461
Osiri M, Deesomchok U, Tugwell P (2001) Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology (Oxford, England) 40(5):555–558
Vander Cruyssen B, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, Veys EM, Mielants H, De Clerck L, Peretz A, Malaise M, Verbruggen L, Vastesaeger N, Geldhof A, Boullart L, De Keyser F (2005) DAS28 best reflects the physician’s clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther 7(5):R1063–R1071. https://doi.org/10.1186/ar1787
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10):1727–1736. https://doi.org/10.1007/s11136-011-9903-x
Nilchaikovit TLM, Phisansuthidth U (1996) Development of Thai version of hospital anxiety and depression scale in cancer patients. J Psychiatr Assoc Thai 41(1):18–31
Shin SY, Katz P, Julian L (2013) Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis. Arthritis Care Res 65(3):481–486. https://doi.org/10.1002/acr.21814
Baptista TSA, Petersen LE, Molina JK, de Nardi T, Wieck A, do Prado A, Piovesan DM, Keisermann M, Grassi-Oliveira R, Bauer ME (2017) Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis. Clin Rheumatol 36(9):1959–1968. https://doi.org/10.1007/s10067-017-3724-4
Lee JH, Kim GT, Kim YK, Lee SG (2018) Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes. Clin Exp Rheumatol 36(5):856–861
Petersen LE, Baptista TSA, Molina JK, Motta JG, do Prado A, Piovesan DM, de Nardi T, Viola TW, Vieira ELM, Teixeira AL, Grassi-Oliveira R, Bauer ME (2018) Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors. Clin Rheumatol 37(5):1171–1181. https://doi.org/10.1007/s10067-018-3990-9
Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F (2015) Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4240–4248. https://doi.org/10.1210/jc.2015-2046
Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF (2016) Hemoglobin, anemia, and cognitive function: the atherosclerosis risk in communities study. J Gerontol A Biol Sci Med Sci 71(6):772–779. https://doi.org/10.1093/gerona/glv158
Morris MS, Jacques PF, Rosenberg IH, Selhub J (2007) Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85(1):193–200. https://doi.org/10.1093/ajcn/85.1.193
Acknowledgements
We thank Ms. Khemajira Karaketklang for her assistance in the statistical analysis, Ms. Wanwisa Chanapai and Mrs. Phakhamon Thaweeratthakul for the data collection and management, and Ms. Ananya Srisomnuek and Ms. Wanlika Kaewkhunthong for performing the MoCA test.
Financial support
This study was supported by a Thai Rheumatism Association research grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and adhered to the principles outlined in the Guideline for Good Clinical Practice International Conference on Harmonization (ICH) Tripartite Guideline (January 1997). The study protocol was approved by local ethics committees, the Siriraj Institutional Review Board and the Institutional Review Board of the Royal Thai Army Medical Department.
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Katchamart, W., Narongroeknawin, P., Phutthinart, N. et al. Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis. Clin Rheumatol 38, 1851–1856 (2019). https://doi.org/10.1007/s10067-019-04488-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04488-3